Frontiers in Oncology (May 2022)
Surgical Management of Falcotentorial Junction Tumors: A Case Series Report
- Peixi Liu,
- Peixi Liu,
- Peixi Liu,
- Peixi Liu,
- Peixi Liu,
- Xiaowen Wang,
- Xiaowen Wang,
- Xiaowen Wang,
- Xiaowen Wang,
- Xiaowen Wang,
- Yingjun Liu,
- Yingjun Liu,
- Yingjun Liu,
- Yingjun Liu,
- Yingjun Liu,
- Jiajun Cai,
- Jiajun Cai,
- Jiajun Cai,
- Jiajun Cai,
- Jiajun Cai,
- Zixiao Yang,
- Zixiao Yang,
- Zixiao Yang,
- Zixiao Yang,
- Zixiao Yang,
- Kai Quan,
- Kai Quan,
- Kai Quan,
- Kai Quan,
- Kai Quan,
- Wei Zhu,
- Wei Zhu,
- Wei Zhu,
- Wei Zhu,
- Wei Zhu,
- Jianping Song,
- Jianping Song,
- Jianping Song,
- Jianping Song,
- Jianping Song
Affiliations
- Peixi Liu
- Department of Neurosurgery, Huashan Hospital, Shanghai Medical College, Fudan University, Shanghai, China
- Peixi Liu
- National Center for Neurological Disorders, Fudan University, Shanghai, China
- Peixi Liu
- Shanghai Key Laboratory of Brain Function and Restoration and Neural Regeneration, Fudan University, Shanghai, China
- Peixi Liu
- Neurosurgical Institute, Fudan University, Shanghai, China
- Peixi Liu
- Shanghai Clinical Medical Center of Neurosurgery, Fudan University, Shanghai, China
- Xiaowen Wang
- Department of Neurosurgery, Huashan Hospital, Shanghai Medical College, Fudan University, Shanghai, China
- Xiaowen Wang
- National Center for Neurological Disorders, Fudan University, Shanghai, China
- Xiaowen Wang
- Shanghai Key Laboratory of Brain Function and Restoration and Neural Regeneration, Fudan University, Shanghai, China
- Xiaowen Wang
- Neurosurgical Institute, Fudan University, Shanghai, China
- Xiaowen Wang
- Shanghai Clinical Medical Center of Neurosurgery, Fudan University, Shanghai, China
- Yingjun Liu
- Department of Neurosurgery, Huashan Hospital, Shanghai Medical College, Fudan University, Shanghai, China
- Yingjun Liu
- National Center for Neurological Disorders, Fudan University, Shanghai, China
- Yingjun Liu
- Shanghai Key Laboratory of Brain Function and Restoration and Neural Regeneration, Fudan University, Shanghai, China
- Yingjun Liu
- Neurosurgical Institute, Fudan University, Shanghai, China
- Yingjun Liu
- Shanghai Clinical Medical Center of Neurosurgery, Fudan University, Shanghai, China
- Jiajun Cai
- Department of Neurosurgery, Huashan Hospital, Shanghai Medical College, Fudan University, Shanghai, China
- Jiajun Cai
- National Center for Neurological Disorders, Fudan University, Shanghai, China
- Jiajun Cai
- Shanghai Key Laboratory of Brain Function and Restoration and Neural Regeneration, Fudan University, Shanghai, China
- Jiajun Cai
- Neurosurgical Institute, Fudan University, Shanghai, China
- Jiajun Cai
- Shanghai Clinical Medical Center of Neurosurgery, Fudan University, Shanghai, China
- Zixiao Yang
- Department of Neurosurgery, Huashan Hospital, Shanghai Medical College, Fudan University, Shanghai, China
- Zixiao Yang
- National Center for Neurological Disorders, Fudan University, Shanghai, China
- Zixiao Yang
- Shanghai Key Laboratory of Brain Function and Restoration and Neural Regeneration, Fudan University, Shanghai, China
- Zixiao Yang
- Neurosurgical Institute, Fudan University, Shanghai, China
- Zixiao Yang
- Shanghai Clinical Medical Center of Neurosurgery, Fudan University, Shanghai, China
- Kai Quan
- Department of Neurosurgery, Huashan Hospital, Shanghai Medical College, Fudan University, Shanghai, China
- Kai Quan
- National Center for Neurological Disorders, Fudan University, Shanghai, China
- Kai Quan
- Shanghai Key Laboratory of Brain Function and Restoration and Neural Regeneration, Fudan University, Shanghai, China
- Kai Quan
- Neurosurgical Institute, Fudan University, Shanghai, China
- Kai Quan
- Shanghai Clinical Medical Center of Neurosurgery, Fudan University, Shanghai, China
- Wei Zhu
- Department of Neurosurgery, Huashan Hospital, Shanghai Medical College, Fudan University, Shanghai, China
- Wei Zhu
- National Center for Neurological Disorders, Fudan University, Shanghai, China
- Wei Zhu
- Shanghai Key Laboratory of Brain Function and Restoration and Neural Regeneration, Fudan University, Shanghai, China
- Wei Zhu
- Neurosurgical Institute, Fudan University, Shanghai, China
- Wei Zhu
- Shanghai Clinical Medical Center of Neurosurgery, Fudan University, Shanghai, China
- Jianping Song
- Department of Neurosurgery, Huashan Hospital, Shanghai Medical College, Fudan University, Shanghai, China
- Jianping Song
- National Center for Neurological Disorders, Fudan University, Shanghai, China
- Jianping Song
- Shanghai Key Laboratory of Brain Function and Restoration and Neural Regeneration, Fudan University, Shanghai, China
- Jianping Song
- Neurosurgical Institute, Fudan University, Shanghai, China
- Jianping Song
- Shanghai Clinical Medical Center of Neurosurgery, Fudan University, Shanghai, China
- DOI
- https://doi.org/10.3389/fonc.2022.866225
- Journal volume & issue
-
Vol. 12
Abstract
ObjectiveThe surgical strategy for falcotentorial junction tumors remains complex. Different approaches are selected according to the location and growth pattern of the tumor and the operator’s experience. This report reviews our single-institution experience in the surgical management of falcotentorial junction tumors.MethodsWe retrospectively reviewed the clinical and imaging data, surgical strategy, and follow-up outcomes of 49 patients treated from 2007 to 2020.ResultAll 49 patients (12 male, 37 female, mean age: 56.3 ± 11.3 years) underwent safe tumor resection. The most common complaints were headache (43%), dizziness (39%), and unstable gait (16%). Thirty percent of the tumors showed calcification, and the computed tomography scans revealed hydrocephalus in 36% of the patients. On magnetic resonance imaging, 43% of the tumors were unilateral. According to the Asari classification, the tumors were divided into inferior (16%), superior (29%), anterior (22%), and posterior (33%) types. The occipital interhemispheric approach (88%) and supracerebellar–infratentorial approach (10%) were primarily used to reach the tumors. The pathology examination results revealed that 85.7% of the tumors were meningioma and 14.3% were hemangiopericytoma. Of the 49 patients, 15 achieved a Simpson grade I resection, and 29 achieved a Simpson grade II resection. The follow-up rate was 77.6% (38/45); 94.7% of patients (36/38) achieved a favorable outcome, and 9 experienced tumor recurrences.ConclusionSurgical approach selection depends on the growth characteristics of the tumor and the degree of venous or sinus involvement. The occipital interhemispheric approach is the most commonly used and safest approach for falcotentorial junction tumors with multiple brain pressure control assistance techniques.
Keywords
